RP-1776, a novel cyclic peptide produced by Streptomyces sp., inhibits the binding of PDGF to the extracellular domain of its receptor

40Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

RP-1776, a novel cyclic peptide, was isolated from the culture broth of Streptomyces sp. KY11784. RP-1776 selectively inhibited the binding of PDGF BB to the extracellular domain of the PDGF β-receptor with an IC50 value of 11±6 μm. Detailed binding experiments suggested that RP-1776 directly interacts with PDGF BB. RP-1776 inhibited the phosphorylation of the PDGF β-receptor induced by PDGF BB. These results suggested that RP-1776 antagonizes the signaling of PDGF BB probably through the inhibition of PDGF BB binding to the PDGF β-receptor.

Cite

CITATION STYLE

APA

Toki, S., Agatsuma, T., Ochiai, K., Saitoh, Y., Ando, K., Nakanishi, S., … Matsuda, Y. (2001). RP-1776, a novel cyclic peptide produced by Streptomyces sp., inhibits the binding of PDGF to the extracellular domain of its receptor. Journal of Antibiotics, 54(5), 405–414. https://doi.org/10.7164/antibiotics.54.405

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free